{
    "clinical_study": {
        "@rank": "90664", 
        "arm_group": [
            {
                "arm_group_label": "Prasugrel 100mg loading dose", 
                "arm_group_type": "Experimental", 
                "description": "Prasugrel 100mg loading dose"
            }, 
            {
                "arm_group_label": "Prasugrel 60mg loading dose", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a prospective, multi-center, non-randomized, controlled study in 2 sequential groups\n      of P2Y12 inhibitor-naive consecutive STEMI patients undergoing primary PCI.  Following\n      aspirin 325 mg LD, patients will receive 60 mg or 100 mg of prasugrel, respectively.\n      Platelet reactivity (PR)will be assessed at Hour 0 (before prasugrel's administration\n      immediately prior to PCI) and at Hours 0.5, 1, 2, 4 thereafter. Platelet function testing\n      (in PRU) will be performed with the VerifyNow (Accumetrics Inc., San Diego, CA, USA) P2Y12\n      function assay."
        }, 
        "brief_title": "High (100mg) Versus Standard (60mg) Loading Dose of Prasugrel in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "condition": "Platelet Reactivity", 
        "condition_browse": {
            "mesh_term": [
                "Infarction", 
                "Myocardial Infarction"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  ST elevation myocardial infarction\n\n          -  Pain onset <12 hours\n\n          -  Age >18 and <75 years\n\n          -  Written informed consent\n\n        Exclusion Criteria:\n\n          -  history of stroke/transient ischemic attack\n\n          -  oral anticoagulation\n\n          -  hemodynamic instability\n\n          -  platelet count <100000/\u03bcL\n\n          -  hematocrit <30%\n\n          -  creatinine clearance <30 ml/min\n\n          -  severe hepatic dysfunction\n\n          -  active bleeding\n\n          -  weight <60 Kg\n\n          -  periprocedural IIb/IIIa inhibitor administration"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "74 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "82", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01835353", 
            "org_study_id": "PATRASCARDIOLOGY-13"
        }, 
        "intervention": [
            {
                "arm_group_label": "Prasugrel 100mg loading dose", 
                "intervention_name": "Prasugrel 100mg loading dose", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Prasugrel 60mg loading dose", 
                "description": "Prasugrel 60mg loading dose", 
                "intervention_name": "Prasugrel 60mg loading dose", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Prasugrel"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "prasugrel", 
            "ST elevation myocardial infarction"
        ], 
        "lastchanged_date": "September 20, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Patras", 
                    "country": "Greece", 
                    "state": "Achaia", 
                    "zip": "26500"
                }, 
                "name": "Dimitrios Alexopoulos"
            }
        }, 
        "location_countries": {
            "country": "Greece"
        }, 
        "number_of_arms": "2", 
        "official_title": "High (100mg) Versus Standard (60mg) Loading Dose of Prasugrel in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Greece: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Platelet reactivity in Platelet reactivity units (PRU) 2 hours post randomization", 
            "measure": "Platelet reactivity in Platelet reactivity units (PRU) at Hour 2", 
            "safety_issue": "No", 
            "time_frame": "2 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01835353"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Patras", 
            "investigator_full_name": "Dimitrios Alexopoulos", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Platelet reactivity in platelet reactivity units (PRU)1 hour post randomization", 
                "measure": "Platelet reactivity in platelet reactivity units (PRU)at hour 1", 
                "safety_issue": "No", 
                "time_frame": "1 hour"
            }, 
            {
                "description": "Platelet reactivity in platelet reactivity units (PRU)0.5 hour post randomization", 
                "measure": "Platelet reactivity in platelet reactivity units (PRU)at hour 0.5", 
                "safety_issue": "No", 
                "time_frame": "0.5 hours"
            }, 
            {
                "description": "Platelet reactivity in platelet reactivity units (PRU)4 hours post randomization", 
                "measure": "Platelet reactivity in platelet reactivity units (PRU)at hour 4", 
                "safety_issue": "No", 
                "time_frame": "4 hours"
            }, 
            {
                "description": "High platelet reactivity rate (208 PRU threshold) 0.5 hour post randomization", 
                "measure": "High platelet reactivity rate (208 PRU threshold) at 0.5 hour", 
                "safety_issue": "No", 
                "time_frame": "0.5 hour"
            }, 
            {
                "description": "High platelet reactivity rate (208 PRU threshold) 1 hour post randomization", 
                "measure": "High platelet reactivity rate (208 PRU threshold) at 1 hour", 
                "safety_issue": "No", 
                "time_frame": "1 hour"
            }, 
            {
                "description": "High platelet reactivity rate (208 PRU threshold) 2 hours post randomization", 
                "measure": "High platelet reactivity rate (208 PRU threshold) at 2 hour", 
                "safety_issue": "No", 
                "time_frame": "2 hours"
            }, 
            {
                "description": "High platelet reactivity rate (208 PRU threshold) 4 hours post randomization", 
                "measure": "High platelet reactivity rate (208 PRU threshold) at 4 hour", 
                "safety_issue": "No", 
                "time_frame": "4 hours"
            }
        ], 
        "source": "University of Patras", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Patras", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}